-
14-bromo-8,18-diazatetracyclo[9.7.0.02,7.012,17]octadeca-1(11),2,4,6,12,14,16-heptaen-9-one
-
ChemBase ID:
153739
-
Molecular Formular:
C16H11BrN2O
-
Molecular Mass:
327.17534
-
Monoisotopic Mass:
326.00547498
-
SMILES and InChIs
SMILES:
c1ccc2c(c1)c1c(c3cc(ccc3[nH]1)Br)CC(=O)N2
Canonical SMILES:
O=C1Nc2ccccc2c2c(C1)c1cc(Br)ccc1[nH]2
InChI:
InChI=1S/C16H11BrN2O/c17-9-5-6-14-11(7-9)12-8-15(20)18-13-4-2-1-3-10(13)16(12)19-14/h1-7,19H,8H2,(H,18,20)
InChIKey:
QQUXFYAWXPMDOE-UHFFFAOYSA-N
-
Cite this record
CBID:153739 http://www.chembase.cn/molecule-153739.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
14-bromo-8,18-diazatetracyclo[9.7.0.02,7.012,17]octadeca-1(11),2,4,6,12,14,16-heptaen-9-one
|
14-bromo-8,18-diazatetracyclo[9.7.0.02,7.012,17]octadeca-1(11),2(7),3,5,12,14,16-heptaen-9-one
|
|
|
IUPAC Traditional name
|
14-bromo-8,18-diazatetracyclo[9.7.0.02,7.012,17]octadeca-1(11),2,4,6,12,14,16-heptaen-9-one
|
14-bromo-8,18-diazatetracyclo[9.7.0.02,7.012,17]octadeca-1(11),2(7),3,5,12,14,16-heptaen-9-one
|
|
|
Synonyms
|
9-Bromo-7,12-dihydro-indolo-[3,2-d]-[1]benzazepin-6(5H)-one
|
NSC 664704
|
Kenpaullone
|
9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one
|
9-Bromopaullone
|
Kenpaullone
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.954072
|
H Acceptors
|
1
|
H Donor
|
2
|
LogD (pH = 5.5)
|
3.5067914
|
LogD (pH = 7.4)
|
3.5067902
|
Log P
|
3.5067914
|
Molar Refractivity
|
83.3079 cm3
|
Polarizability
|
33.262077 Å3
|
Polar Surface Area
|
44.89 Å2
|
Rotatable Bonds
|
0
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
TRC
Sigma Aldrich -
K3888
|
Biochem/physiol Actions Kenpaullone is a potent inhibitor of CDK1/cyclin B (IC50 = 400 nM), CDK2/cyclin A (IC50 = 680 nM), CDK2/cyclin E (IC50 = 7.5 uM) and CDK5/p25 (IC50 = 850 nM). Packaging Store under argon |
Toronto Research Chemicals -
K162500
|
The paullones are a novel class of kinase inhibitors, initially identified as CDK inhibitors. Kenpaullone has been found to be a useful GSK-3β inhibitor (IC50=23nM). |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Zaharevitz, D.W., et al.: Cancer Res., 59, 2566 (1999)
- • Leclerc, S., et al.: J. Biol. Chem., 276, 251 (1999)
- • Bain, J., et al.: Biochem. J., in press.
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent